Robert J. Sheppard

2.7k total citations
22 papers, 617 citations indexed

About

Robert J. Sheppard is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Robert J. Sheppard has authored 22 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Robert J. Sheppard's work include Protein Degradation and Inhibitors (7 papers), Chemical Synthesis and Analysis (4 papers) and Peptidase Inhibition and Analysis (4 papers). Robert J. Sheppard is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Chemical Synthesis and Analysis (4 papers) and Peptidase Inhibition and Analysis (4 papers). Robert J. Sheppard collaborates with scholars based in United Kingdom, Sweden and Germany. Robert J. Sheppard's co-authors include Richard L. Jarvest, Peter J. O’Hanlon, Andrew K. Forrest, Rab K. Prinjha, Emmanuel H. Demont, Paul Bamborough, Robert J. Watson, Chun‐wa Chung, Darren J. Mitchell and Paola Grandi and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Biochemistry.

In The Last Decade

Robert J. Sheppard

21 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Sheppard United Kingdom 15 480 129 111 65 59 22 617
Mark E. Zupec United States 15 326 0.7× 115 0.9× 38 0.3× 91 1.4× 61 1.0× 18 546
S. Lovell United States 14 280 0.6× 149 1.2× 38 0.3× 115 1.8× 76 1.3× 23 511
P.A. Elkins United States 10 597 1.2× 138 1.1× 23 0.2× 94 1.4× 50 0.8× 10 862
Neeraj K. Mishra United States 11 390 0.8× 66 0.5× 85 0.8× 29 0.4× 34 0.6× 19 517
John F. Lynas United Kingdom 10 344 0.7× 92 0.7× 30 0.3× 124 1.9× 28 0.5× 18 470
Kesavan Radika United States 13 321 0.7× 133 1.0× 46 0.4× 60 0.9× 36 0.6× 15 616
David G. Osterman United States 13 510 1.1× 61 0.5× 27 0.2× 48 0.7× 35 0.6× 16 672
J.-P. Marquette France 9 358 0.7× 61 0.5× 24 0.2× 47 0.7× 50 0.8× 9 644
James Wells United States 5 646 1.3× 68 0.5× 43 0.4× 88 1.4× 16 0.3× 6 815
Sandra Lightle United States 10 279 0.6× 96 0.7× 14 0.1× 41 0.6× 43 0.7× 10 469

Countries citing papers authored by Robert J. Sheppard

Since Specialization
Citations

This map shows the geographic impact of Robert J. Sheppard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Sheppard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Sheppard more than expected).

Fields of papers citing papers by Robert J. Sheppard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Sheppard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Sheppard. The network helps show where Robert J. Sheppard may publish in the future.

Co-authorship network of co-authors of Robert J. Sheppard

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Sheppard. A scholar is included among the top collaborators of Robert J. Sheppard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Sheppard. Robert J. Sheppard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richardson, Paul, Marian C. Bryan, Louis J. Diorazio, et al.. (2025). Solvent Sustainability in Drug Discovery: Where Are We Now, and How Can We Improve?. Journal of Medicinal Chemistry. 68(24). 25625–25664.
2.
Yu, Yuqi, Christian Schnepel, Charlotte Morrill, et al.. (2023). Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters. Journal of the American Chemical Society. 145(40). 22041–22046. 11 indexed citations
3.
Holdgate, Geoffrey A., Catherine Bardelle, Jon Read, et al.. (2021). Drug discovery for epigenetics targets. Drug Discovery Today. 27(4). 1088–1098. 22 indexed citations
4.
Lucas, Simon C. C., Stephen J. Atkinson, Paul Bamborough, et al.. (2020). Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode. Journal of Medicinal Chemistry. 63(10). 5212–5241. 16 indexed citations
5.
Bosma, Reggie, Leigh A. Stoddart, Victoria Georgi, et al.. (2019). Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor. Scientific Reports. 9(1). 7906–7906. 17 indexed citations
6.
Bosma, Reggie, Zhiyong Wang, Albert J. Kooistra, et al.. (2019). Route to Prolonged Residence Time at the Histamine H 1 Receptor: Growing from Desloratadine to Rupatadine. Journal of Medicinal Chemistry. 62(14). 6630–6644. 19 indexed citations
7.
Bamborough, Paul, Chun‐wa Chung, Rebecca C. Furze, et al.. (2018). Aiming to Miss a Moving Target: Bromo and Extra Terminal Domain (BET) Selectivity in Constrained ATAD2 Inhibitors. Journal of Medicinal Chemistry. 61(18). 8321–8336. 18 indexed citations
8.
Xia, Lizi, Henk de Vries, Eelke B. Lenselink, et al.. (2017). Structure–Affinity Relationships and Structure–Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists. Journal of Medicinal Chemistry. 60(23). 9545–9564. 6 indexed citations
9.
Hothersall, Joanne, Dong Guo, Sunil Sarda, et al.. (2016). Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics. Molecular Pharmacology. 91(1). 25–38. 22 indexed citations
10.
Bamborough, Paul, Chun‐wa Chung, Emmanuel H. Demont, et al.. (2016). A Chemical Probe for the ATAD2 Bromodomain. Angewandte Chemie. 128(38). 11554–11558. 10 indexed citations
11.
Bamborough, Paul, Chun‐wa Chung, Emmanuel H. Demont, et al.. (2016). A Chemical Probe for the ATAD2 Bromodomain. Angewandte Chemie International Edition. 55(38). 11382–11386. 51 indexed citations
12.
Joberty, Gérard, Markus Böesche, Jack A. Brown, et al.. (2016). Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical Proteomics. ACS Chemical Biology. 11(7). 2002–2010. 23 indexed citations
13.
Demont, Emmanuel H., Paul Bamborough, Chun‐wa Chung, et al.. (2014). 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain. ACS Medicinal Chemistry Letters. 5(11). 1190–1195. 68 indexed citations
14.
Jarvest, Richard L., Symon G. Erskine, Andrew K. Forrest, et al.. (2005). Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2305–2309. 19 indexed citations
15.
Jarvest, Richard L., John M. Berge, Murray J. B. Brown, et al.. (2003). Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 13(4). 665–668. 32 indexed citations
16.
Jarvest, Richard L., John M. Berge, Valerie Berry, et al.. (2002). Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens. Journal of Medicinal Chemistry. 45(10). 1959–1962. 92 indexed citations
17.
Forrest, Andrew K., et al.. (2000). Aminoalkyl adenylate and aminoacyl sulfamate intermediate analogues differing greatly in affinity for their cognate Staphylococcus aureus aminoacyl tRNA synthetases. Bioorganic & Medicinal Chemistry Letters. 10(16). 1871–1874. 54 indexed citations
18.
Wilmouth, R.C., Nicholas J. Westwood, Robert J. Sheppard, et al.. (1999). Mechanistic Insights into the Inhibition of Serine Proteases by Monocyclic Lactams,. Biochemistry. 38(25). 7989–7998. 60 indexed citations
19.
Miller, George, et al.. (1979). An Extensive Salmonella Typhimurium Outbreak of Probable Waterborne Origin. American Water Works Association. 71(5). 287–291. 1 indexed citations
20.
Paton, J., et al.. (1952). A CASE OF BRUCELLOSIS WITH ACUTE PORPHYRIA. The Medical Journal of Australia. 1(23). 781–784. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark E. Zupec Breakdown of academic impact, for papers by S. Lovell Breakdown of academic impact, for papers by P.A. Elkins Breakdown of academic impact, for papers by Neeraj K. Mishra Breakdown of academic impact, for papers by John F. Lynas Breakdown of academic impact, for papers by Kesavan Radika Breakdown of academic impact, for papers by David G. Osterman Breakdown of academic impact, for papers by J.-P. Marquette Breakdown of academic impact, for papers by James Wells Breakdown of academic impact, for papers by Sandra Lightle
Rankless by CCL
2026